Metoprolol and Telmisartan Do Not Typically Cause Polyuria
Neither metoprolol nor telmisartan is associated with polyuria as a common side effect. In fact, telmisartan is more commonly associated with potential renal impairment rather than increased urine output 1.
Telmisartan and Renal Effects
- Telmisartan, an angiotensin II receptor blocker (ARB), actually tends to reduce proteinuria and has renoprotective effects in patients with chronic kidney disease 2, 3
- The FDA drug label for telmisartan lists potential renal adverse effects including:
- Telmisartan can cause efferent arteriolar vasodilation, which may actually decrease glomerular filtration rate rather than increase it 4
Metoprolol and Renal Effects
- Beta-blockers like metoprolol are not typically associated with polyuria 4
- Common adverse effects of beta-blockers include:
Medications That Can Cause Polyuria
- Vasopressin antagonists (like tolvaptan) are known to cause substantial polyuria, which can affect sleep and daily activities 4
- Diuretics, particularly loop diuretics, can cause increased urine output, but this is typically described as diuresis rather than polyuria 4
- The ONTARGET study, which examined telmisartan and ramipril, did not report polyuria as an adverse effect 5
Clinical Implications
- When monitoring patients on telmisartan:
- For patients on metoprolol:
Special Considerations
- In patients with chronic kidney disease, telmisartan has been shown to reduce proteinuria by approximately 37% in some studies 7
- The combination of ARBs with diuretics may increase risk of acute kidney injury, especially in patients with bilateral renal artery stenosis, dehydration, or pre-existing kidney disease 6
- If a patient on these medications reports polyuria, consider other causes or concomitant medications rather than attributing it to metoprolol or telmisartan 4